These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6072669)

  • 1. Power of the package insert.
    Chayet NL
    N Engl J Med; 1967 Dec; 277(23):1253-4. PubMed ID: 6072669
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug reactions: the role of the package insert.
    Barnett FJ
    J Leg Med (N Y); 1973; 1(1):19-23. PubMed ID: 4548069
    [No Abstract]   [Full Text] [Related]  

  • 3. The medicolegal significance of the package insert.
    Hirsh HL
    Conn Med; 1978 Dec; 42(12):785-8. PubMed ID: 720048
    [No Abstract]   [Full Text] [Related]  

  • 4. Legal implications of the package insert.
    Temple R
    Med Clin North Am; 1974 Sep; 58(5):1151-9. PubMed ID: 4421680
    [No Abstract]   [Full Text] [Related]  

  • 5. The medicolegal significance of the package insert.
    Hirsh HL
    J Fam Pract; 1977 Jun; 4(6):1141-3. PubMed ID: 874441
    [No Abstract]   [Full Text] [Related]  

  • 6. The medicolegal significance of the package insert.
    Hirsh HL
    Med Trial Tech Q; 1976; 23(2):143-50. PubMed ID: 1004155
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmaceutical inserts: legal consequences.
    Hirsh HL
    Hosp Med Staff; 1979 Jul; 8(7):2-6. PubMed ID: 10242674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The package insert and the pharmacist's liability.
    Simonsmeier LM
    Am J Pharm Sci Support Public Health; 1977; 149(3):82-9. PubMed ID: 596428
    [No Abstract]   [Full Text] [Related]  

  • 9. The package insert.
    JAMA; 1969 Feb; 207(7):1342. PubMed ID: 5818327
    [No Abstract]   [Full Text] [Related]  

  • 10. The drug package insert: useful information or the practice of medicine.
    Curran WJ
    Am J Public Health; 1972 Mar; 62(3):435. PubMed ID: 5011176
    [No Abstract]   [Full Text] [Related]  

  • 11. Notes on the package insert.
    JAMA; 1969 Feb; 207(7):1335-8. PubMed ID: 5818325
    [No Abstract]   [Full Text] [Related]  

  • 12. American Academy of Pediatrics Committee on Drugs. "Therapeutic orphans" and the package insert.
    Pediatrics; 1970 Nov; 46(5):811-3. PubMed ID: 5536437
    [No Abstract]   [Full Text] [Related]  

  • 13. New pediatric dosage rules: information and testing.
    Feeg VD
    Pediatr Nurs; 1998; 24(6):518, 613. PubMed ID: 10085992
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA problems with medications in the marketplace: III. 'Therapeutic orphans'.
    Archambault GF
    Hosp Formul; 1976 Dec; 11(12):690. PubMed ID: 1028797
    [No Abstract]   [Full Text] [Related]  

  • 15. Prescription drug products; patient package insert requirements--Food and Drug Administration. Final rule.
    Fed Regist; 1981 Jan; 46(1):28-30. PubMed ID: 10324121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The medico-legal aspects of drug interactions.
    Goldstein EM
    J Forensic Sci; 1973 Oct; 18(4):335-43. PubMed ID: 4784302
    [No Abstract]   [Full Text] [Related]  

  • 17. Paediatric clinical trials: redressing the imbalance.
    Schreiner MS
    Nat Rev Drug Discov; 2003 Dec; 2(12):949-61. PubMed ID: 14654794
    [No Abstract]   [Full Text] [Related]  

  • 18. Sounding board. Hegemony in medicine revisited.
    Chayet NL
    N Engl J Med; 1976 Mar; 294(10):547-8. PubMed ID: 1250259
    [No Abstract]   [Full Text] [Related]  

  • 19. Labeling regulations: 'prescribe as directed'.
    Regier H
    J Leg Med (N Y); 1974; 2(5):48-51. PubMed ID: 4548706
    [No Abstract]   [Full Text] [Related]  

  • 20. Prescription drug products that require patient package inserts; ampicillin and phenytoin--Food and Drug Administration. Final rule.
    Fed Regist; 1981 Jan; 46(1):28. PubMed ID: 10249520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.